RT Journal Article
SR Electronic
T1 Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New Zealand
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.20.20073437
DO 10.1101/2020.04.20.20073437
A1 Nicholas Steyn
A1 Rachelle N. Binny
A1 Kate Hannah
A1 Shaun C. Hendy
A1 Alex James
A1 Tahu Kukutai
A1 Audrey Lustig
A1 Melissa McLeod
A1 Michael J. Plank
A1 Kannan Ridings
A1 Andrew Sporle
YR 2020
UL http://medrxiv.org/content/early/2020/04/24/2020.04.20.20073437.abstract
AB There is limited evidence as to how COVID-19 infection fatality rates (IFR) may vary by ethnicity. We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity. We find that, if age is the dominant factor determining IFR, estimated IFR for Māori is around 50% higher than non-Māori. If underlying health conditions are more important than age per se, then estimated IFR for Māori is more than 2.5 times that of New Zealand European, and estimated IFR for Pasifika is almost double that of New Zealand European. IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities not reflected in official data. IFR does not account for differences among ethnicities in COVID-19 incidence, which could be higher in Māori and Pasifika as a result of crowded housing and higher inter- generational contact rates. These factors should be included in future disease incidence modelling. The communities at the highest risk will be those with elderly populations, and Māori and Pasifika communities, where the compounded effects of underlying health conditions, socioeconomic disadvantage, and structural racism result in imbricated risk of contracting COVID-19, becoming unwell, and death.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe article does not present new primary data.